Evidence map›Paper›PMID 29183719›Full record

ReviewAntiviral research2018

The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Ahmed Diab, Adrien Foca, Fabien Zoulim, David Durantel, Ourania Andrisani

Open access · greenAbstract readReview
In one paragraph

Review in Antiviral research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. In Silico Screening of Secondary Metabolites from Scorodocarpus Borneensis as Hepatitis B Virus Inhibitors.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Ahmed DiabDepartment of Basic Medical Sciences and Purdue Center for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA; INSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, 69008, France; University of Lyon, Université Claude-Bernard (UCBL), UMR_S1052, UCBL, 69008, Lyon, France.
Adrien FocaINSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, 69008, France; University of Lyon, Université Claude-Bernard (UCBL), UMR_S1052, UCBL, 69008, Lyon, France.
Fabien ZoulimINSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, 69008, France; University of Lyon, Université Claude-Bernard (UCBL), UMR_S1052, UCBL, 69008, Lyon, France; Hepato-Gastroenterology Unit, Croix-Rousse Hospital, Hospices Civils de Lyon (HCL), 69002, Lyon, France; Labex DEVweCAN, 69008, Lyon, France.
David DurantelINSERM U1052, Cancer Research Center of Lyon (CRCL), Lyon, 69008, France; University of Lyon, Université Claude-Bernard (UCBL), UMR_S1052, UCBL, 69008, Lyon, France; Hepato-Gastroenterology Unit, Croix-Rousse Hospital, Hospices Civils de Lyon (HCL), 69002, Lyon, France. Electronic address: david.durantel@inserm.fr.
Ourania AndrisaniDepartment of Basic Medical Sciences and Purdue Center for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA. Electronic address: andrisao@purdue.edu.
Université Claude Bernard Lyon 1 · FRPurdue University West Lafayette · US

Funding

Role of CREB/ATF Proteins in Hepatocyte Growth ControlR01DK044533 · NIDDK · PURDUE UNIVERSITY WEST LAFAYETTE · PI ANDRISANI, OURANIA M. · 1999 to 2021
$5.1M
NIDDK NIH HHS R01 DK044533
6 · The paper itself

Abstract

Virally encoded proteins have evolved to perform multiple functions, and the core protein (HBc) of the hepatitis B virus (HBV) is a perfect example. While HBc is the structural component of the viral nucleocapsid, additional novel functions for the nucleus-localized HBc have recently been described. These results extend for HBc, beyond its structural role, a regulatory function in the viral life cycle and potentially a role in pathogenesis. In this article, we review the diverse roles of HBc in HBV replication and pathogenesis, emphasizing how the unique structure of this protein is key to its various functions. We focus in particular on recent advances in understanding the significance of HBc phosphorylations, its interaction with host proteins and the role of HBc in regulating the transcription of host genes. We also briefly allude to the emerging niche for new direct-acting antivirals targeting HBc, known as Core (protein) Allosteric Modulators (CAMs).

Indexed as

AnimalsAntiviral AgentsDrug DiscoveryGene Expression Regulation, ViralHepatitis BHepatitis B Core AntigensHepatitis B virusHost-Pathogen InteractionsHumansPhosphorylationProtein BindingProtein TransportViral Core ProteinsAntiviral AgentsHepatitis B Core AntigensViral Core ProteinsCAMsCore allosteric modulatorsHBcHBc phosphorylationsHBc structureHBVHBV core antigenHepatitis B virusPLK1

Identifiers

PMID29183719
PMCPMC5757518
OpenAlexW2768769427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.